Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 14 02:54PM ET
10.19
Dollar change
-0.41
Percentage change
-3.82
%
IndexRUT P/E- EPS (ttm)-1.35 Insider Own13.42% Shs Outstand155.92M Perf Week-5.43%
Market Cap1.59B Forward P/E- EPS next Y-1.02 Insider Trans-0.22% Shs Float134.99M Perf Month-11.12%
Income-138.36M PEG- EPS next Q-0.25 Inst Own80.29% Short Float9.39% Perf Quarter25.71%
Sales61.10M P/S26.02 EPS this Y-17.16% Inst Trans13.40% Short Ratio11.64 Perf Half Y62.60%
Book/sh2.43 P/B4.20 EPS next Y13.71% ROA-43.26% Short Interest12.67M Perf Year363.41%
Cash/sh2.95 P/C3.46 EPS next 5Y- ROE-72.67% 52W Range2.05 - 11.77 Perf YTD128.59%
Dividend Est.- P/FCF- EPS past 5Y8.38% ROI-30.68% 52W High-13.42% Beta1.21
Dividend TTM- Quick Ratio16.55 Sales past 5Y121.20% Gross Margin90.84% 52W Low397.32% ATR (14)0.56
Dividend Ex-Date- Current Ratio16.64 EPS Y/Y TTM5.54% Oper. Margin-187.35% RSI (14)45.56 Volatility4.95% 4.89%
Employees267 Debt/Eq0.20 Sales Y/Y TTM11.90% Profit Margin-226.46% Recom1.11 Target Price16.89
Option/ShortYes / Yes LT Debt/Eq0.19 EPS Q/Q0.38% Payout- Rel Volume1.01 Prev Close10.60
Sales Surprise-9.94% EPS Surprise9.35% Sales Q/Q8.26% EarningsNov 14 BMO Avg Volume1.09M Price10.19
SMA20-6.29% SMA503.31% SMA20027.32% Trades Volume922,718 Change-3.82%
Date Action Analyst Rating Change Price Target Change
Oct-16-24Initiated Scotiabank Sector Outperform
Jun-20-24Upgrade TD Cowen Hold → Buy $7 → $11
May-31-24Resumed Piper Sandler Overweight $15
Feb-09-24Initiated BofA Securities Buy $15
Apr-21-23Initiated Robert W. Baird Outperform $18
Aug-10-22Resumed Berenberg Buy $15
Aug-10-21Upgrade H.C. Wainwright Neutral → Buy $17
Dec-28-20Downgrade H.C. Wainwright Buy → Neutral
Dec-17-20Initiated Berenberg Buy $27
Nov-13-20Reiterated Raymond James Strong Buy $15 → $25
Today 08:40AM
07:37AM
07:00AM
Nov-13-24 07:30AM
07:17AM
07:30AM Loading…
Nov-12-24 07:30AM
Nov-06-24 07:30AM
Oct-15-24 07:30AM
Oct-14-24 09:59AM
Oct-09-24 04:05PM
07:30AM
Oct-08-24 08:50AM
Sep-25-24 07:30AM
Sep-12-24 04:05PM
Sep-05-24 07:30AM
07:30AM Loading…
Sep-04-24 07:30AM
Aug-09-24 09:55AM
07:30AM
Aug-07-24 08:45AM
07:38AM
07:10AM
07:00AM
Jul-31-24 07:30AM
Jul-30-24 07:30AM
Jul-18-24 04:05PM
Jul-10-24 08:00AM
Jul-08-24 04:05PM
Jun-13-24 04:05PM
Jun-05-24 07:30AM
Jun-04-24 04:05PM
09:01PM Loading…
May-07-24 09:01PM
06:07PM
04:41PM
04:05PM
May-06-24 08:16PM
07:30AM
May-03-24 07:30AM
May-01-24 07:30AM
Apr-24-24 08:30AM
Apr-18-24 03:37PM
07:00AM
Apr-16-24 04:30PM
07:00AM
Apr-15-24 07:00AM
Apr-09-24 09:35AM
07:30AM
Apr-06-24 10:00AM
Apr-01-24 10:09AM
Mar-26-24 07:30AM
Mar-13-24 06:38AM
Mar-12-24 09:55AM
Mar-11-24 05:32PM
05:25PM
04:26PM
04:05PM
Mar-05-24 07:30AM
Mar-01-24 06:30PM
Feb-29-24 08:52AM
Feb-28-24 01:40PM
Feb-26-24 12:00PM
10:00AM
Feb-25-24 02:02PM
Feb-22-24 07:32AM
07:31AM
07:30AM
Feb-21-24 09:55AM
Feb-19-24 09:00AM
Feb-18-24 08:00PM
Feb-15-24 08:00AM
Feb-13-24 07:37AM
Feb-12-24 06:27AM
Jan-30-24 09:55AM
Jan-25-24 08:00AM
Jan-10-24 08:44AM
Jan-03-24 01:15PM
Dec-18-23 04:01PM
Dec-13-23 10:09PM
04:01PM
Nov-08-23 05:18PM
08:00AM
Nov-07-23 06:47PM
04:01PM
Nov-01-23 08:00AM
07:06AM
Oct-31-23 09:00AM
Oct-30-23 09:35PM
Oct-24-23 08:00AM
Oct-03-23 04:01PM
Sep-19-23 09:00PM
Sep-06-23 08:00AM
Aug-09-23 08:00AM
Aug-08-23 11:13AM
Aug-07-23 07:15PM
06:05PM
04:01PM
Jul-24-23 08:00AM
Jul-14-23 06:59AM
Jul-13-23 09:00AM
Jul-12-23 08:00AM
Jun-10-23 06:30PM
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PHILIP C. STRASSBURGEROfficerOct 16 '24Proposed Sale10.2313,125134,269Oct 16 04:25 PM
Nayak SanjayChief Strategy OfficerAug 23 '24Sale9.021,83216,525176,194Aug 27 05:19 PM
Dugel PravinSee RemarksAug 23 '24Sale9.0220,880188,338812,473Aug 27 05:17 PM
RABIA OZDENOfficerAug 27 '24Proposed Sale9.0018,333164,997Aug 27 04:18 PM
PRAVIN DUGELOfficerAug 23 '24Proposed Sale9.0220,880188,271Aug 23 05:10 PM
SANJAY NAYAKOfficerAug 23 '24Proposed Sale9.021,83216,526Aug 23 04:36 PM
RABIA OZDENOfficerAug 21 '24Proposed Sale8.9010,00089,047Aug 21 05:32 PM
RABIA OZDENOfficerAug 07 '24Proposed Sale8.5015,000127,500Aug 07 04:15 PM
ANTONY MATTESSICHFormer OfficerAug 01 '24Proposed Sale8.1923,979196,498Aug 01 04:30 PM
LINDSTROM RICHARD L MDDirectorFeb 27 '24Option Exercise8.8030,302266,658150,704Jul 26 07:30 PM
Nayak SanjayChief Strategy OfficerMay 23 '24Sale5.842,27413,280178,026May 28 05:01 PM
Dugel PravinSee RemarksMay 23 '24Sale5.7921,626125,215833,353May 28 05:00 PM
SUMMER ROAD LLC10% OwnerFeb 26 '24Buy7.52930,8517,000,0008,591,401Feb 27 04:43 PM
Notman DonaldChief Financial OfficerJan 31 '24Sale4.956,43331,843139,932Feb 02 07:03 PM
Ozden Rabia GursesChief Medical OfficerJan 31 '24Sale4.957,76438,43292,767Feb 02 07:02 PM
Strassburger Philip C.General CounselJan 31 '24Sale4.956,83133,813109,218Feb 02 07:01 PM
White Christopher GChief Business OfficerJan 31 '24Sale4.955,14725,47889,619Feb 02 07:01 PM
Mattessich Antony C.President and CEOJan 31 '24Sale4.9518,33890,773427,943Feb 02 07:00 PM
SUMMER ROAD LLC10% OwnerDec 14 '23Buy3.251,538,4614,999,9987,660,550Dec 18 04:52 PM